Nico Corporation, an Indianapolis-based neurosurgery medical device manufacturer, completed a $15m investment.
Backers included existing investors River Cities Capital Funds (RCCF) and Rose-Hulman Institute of Technology.
The company intends to use the funds to advance clinical data delivered through a randomized controlled trial, expanded customer training of Nico technology, commercialize new products, expand beyond North America, and hire to support new initiatives.
Led by Jim Pearson, president and CEO, Nico Corporation is a medical device maker dedicated to developing technology for the field of corridor surgery, including cranial, ENT, spinal and otolaryngology, where access to the surgical site is limited. Its technology and products are designed to progress corridor surgery by creating instruments that allow for access through smaller openings and resection of soft tissue abnormalities.